> I think the problem is that Notable Labs would be testing combinations of FDA-approved drugs I assume that only previously used combinations are suggested.

> I think the problem is that Notable Labs would be testing combinations of FDA-approved drugs I assume that only previously used combinations are suggested. > This requirement could turn an 'easy comparison' into a lengthy clinical trial. But at least you would have a fairly reasonable idea of how a clinical trial would go. It's not like going from an animal model to human trials. I assume they can get a large enough sample size as they can probably recruit patients easily for what can be viewed as a second opinion.